In addition, the administration of PEGV-200 dramatically downregulated the expressions of pAKT, pERK, and pIGF-IR in HepG2 and HepG2-SR tumor tissues, which became primarily localized in residual small clusters of tumor cells (Supplementary Figure 4). Here, PIGF is linked to neoplasm.